NOTICE OF FULL YEAR RESULTS-DESTINY PHARMA PLC

NOTICE OF FULL YEAR RESULTS-DESTINY PHARMA PLC

Notice of Full Year Results and Investor Presentation

Brighton, United Kingdom - Destiny Pharma plc (AIM: DEST), a clinical stage innovative biotechnology company focused on the development of novel medicines that can prevent life threatening infections, will announce its financial results for the year ended 31 December 2023, on Thursday 25 April 2024.

Chris Tovey, Chief Executive Officer, and Shaun Claydon, Chief Financial Officer, will host a briefing for analysts at 8.30am BST followed by a presentation to all existing and potential shareholders at 11:00am BST held via the Investor Meet Company platform. Further details for the analyst briefing will be shared by invitation in due course.

Questions can be submitted pre-event via the Investor Meet Company dashboard up until 09:00am BST the day before the meeting, or at any time during the live presentation.

Investors can sign up to Investor Meet Company for free, and add to meet Destiny Pharma

plc via: https://www.investormeetcompany.com/destiny-pharma-plc/register-investor

Investors who already follow Destiny Pharma plc on the Investor Meet Company platform will automatically be invited.

No Comments

Post a Comment